Literature DB >> 31874051

Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study.

Hana Müllerová1, Sarah M Cockle2, Necdet B Gunsoy3, Linda M Nelsen4, Frank C Albers5.   

Abstract

Objectives: Severe asthma (SA) can be uncontrolled despite guideline-directed treatment. We described SA characteristics and identified factors associated with uncontrolled disease and frequent exacerbations.
Methods: Post hoc analysis of the observational IDEAL study (201722/NCT02293265) included patients with SA aged ≥12 years receiving high-dose inhaled corticosteroids plus additional controller(s) for ≥12 months. Uncontrolled SA was defined by Asthma Control Questionnaire (ACQ)-5 scores ≥1.5 or ≥1 exacerbations (prior year), and further stratified by exacerbation frequency (no/infrequent [0-1] vs frequent [≥2]; prior year); associated factors were determined using multivariate logistic regression.
Results: Of 670 patients with SA, 540 (81%) were uncontrolled (ACQ-5 scores ≥1.5: 80%; ≥1 exacerbations [prior year]: 71%). Uncontrolled patients had lower lung function and worse health-related quality of life (HRQoL) than controlled patients; 197/540 (37%) experienced frequent exacerbations (prior year). Worse St George's Respiratory Questionnaire (SGRQ) total score, comorbid sinusitis, or eczema were significantly associated with uncontrolled SA; younger age, never smoker status, exacerbation requiring hospitalization (previous year), worse SGRQ symptom score, comorbid nasal polyps, COPD, or osteoporosis were significantly associated with uncontrolled SA with frequent exacerbations.Conclusions: In IDEAL, one-fifth of patients with SA were controlled, based on symptoms. Uncontrolled, exacerbating SA was associated with specific comorbidities, frequent exacerbations, a lower lung function, and compromised HRQoL, although inference from this analysis is limited by the selective cross-sectional nature of the cohort. Nonetheless, these data highlight the need for more effective precision treatments in this population.

Entities:  

Keywords:  Control/management; morbidity and mortality; quality of life

Year:  2020        PMID: 31874051     DOI: 10.1080/02770903.2019.1708095

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  5 in total

1.  A pilot investigation of e-cigarette use and smoking behaviour among patients with chronic airway disease or respiratory symptoms.

Authors:  Hye Seon Kang; Jae Woo Jung; Hye Jung Park; Dong Il Park; Jong Sook Park; Joo Hun Park; Sang Haak Lee; Eun Mi Chun; Jae Yeol Kim; Hye Sook Choi
Journal:  Clin Respir J       Date:  2021-09-13       Impact factor: 1.761

2.  Severe Asthma in a General Population Study: Prevalence and Clinical Characteristics.

Authors:  Lina Rönnebjerg; Malin Axelsson; Hannu Kankaanranta; Helena Backman; Madeleine Rådinger; Bo Lundbäck; Linda Ekerljung
Journal:  J Asthma Allergy       Date:  2021-09-16

Review 3.  Frontiers Review: Severe Asthma in Adolescents.

Authors:  Sara Warraich; Samatha Sonnappa
Journal:  Front Pediatr       Date:  2022-07-07       Impact factor: 3.569

4.  Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma.

Authors:  Weily Soong; Bradley E Chipps; Sean O'Quinn; Jennifer Trevor; Warner W Carr; Laura Belton; Frank Trudo; Christopher S Ambrose
Journal:  J Asthma Allergy       Date:  2021-06-25

5.  Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes.

Authors:  Charlene M Prazma; Marco Idzko; Jo Anne Douglass; Arnaud Bourdin; Stephen Mallett; Frank C Albers; Steven W Yancey
Journal:  J Asthma Allergy       Date:  2021-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.